Globe Life (GB:0Q1Q)

Globe Life (0Q1Q) Share Price & Analysis


0Q1Q Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€72.48 - €72.48
Previous Close€72.48
Average Volume (3M)N/A
Market Cap
Enterprise Value€11.07B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$447.54M
Price to Earnings (P/E)N/A
Jan 31, 2024
0.9 (1.24%)
Share Statistics
Shares Outstanding94,118,740
10 Day Avg. Volume6,112
30 Day Avg. VolumeN/A
Standard Deviation0.04
Financial Highlights & Ratios
Price to Book (P/B)2.80
Price to Sales (P/S)1.38
Price to Cash Flow (P/CF)10.10
P/FCF Ratio9.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.60
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside66.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9



Ownership Overview

26.15% Mutual Funds
38.20% Other Institutional Investors
32.25% Public Companies and
Individual Investors


What was Globe Life’s price range in the past 12 months?
Globe Life lowest share price was €72.48 and its highest was €72.48 in the past 12 months.
    What is Globe Life’s market cap?
    Currently, no data Available
    When is Globe Life’s upcoming earnings report date?
    Globe Life’s upcoming earnings report date is Jan 31, 2024 which is in 59 days.
      How were Globe Life’s earnings last quarter?
      Globe Life released its earnings results on Oct 25, 2023. The company reported €2.489 earnings per share for the quarter, beating the consensus estimate of €2.436 by €0.053.
        Is Globe Life overvalued?
        According to Wall Street analysts Globe Life’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Globe Life pay dividends?
          Globe Life pays a Quarterly dividend of €0.21 which represents an annual dividend yield of 0.71%. See more information on Globe Life dividends here
            What is Globe Life’s EPS estimate?
            Globe Life’s EPS estimate is €2.51.
              How many shares outstanding does Globe Life have?
              Globe Life has 94,118,740 shares outstanding.
                What happened to Globe Life’s price movement after its last earnings report?
                Globe Life reported an EPS of €2.489 in its last earnings report, beating expectations of €2.436. Following the earnings report the stock price went same 0%.
                  Which hedge fund is a major shareholder of Globe Life?
                  Among the largest hedge funds holding Globe Life’s share is Berkshire Hathaway Inc. It holds Globe Life’s shares valued at 90M.


                    Company Description

                    Globe Life

                    Globe Life, Inc. is a holding company, which engages in the provision of individual life and supplemental health insurance products and services. It operates through the following segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. The Life Insurance segment includes traditional and interest-sensitive whole life insurance as well as term life insurances. The Supplement Health Insurance segment provides generally guaranteed-renewable and include medicare supplement, critical illness, accident, and limited-benefit supplemental hospital, and surgical coverage. The Annuities segment refers to fixed-benefit contracts. The Investments segment covers the investment portfolio. The company was founded on November 19, 1979 and is headquartered in McKinney, TX.


                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Globe Life
                    Prudential Financial
                    Unum Group

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis